These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7544667)

  • 1. [Preoperative prediction of the presence of lymph node metastasis of prostatic carcinoma: reliability and clinical significance].
    Trinchieri A; Nespoli R; Rovera F
    Arch Ital Urol Androl; 1995 Jun; 67(3):203-5. PubMed ID: 7544667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer.
    Narayan P; Fournier G; Gajendran V; Leidich R; Lo R; Wolf JS; Jacob G; Nicolaisen G; Palmer K; Freiha F
    Urology; 1994 Oct; 44(4):519-24. PubMed ID: 7524237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of lymphatic spreading in prostatic cancer by prostate-specific antigen and Gleason's score.
    Wu TT; Chen KK; Huang JK; Lee YH; Chen MT; Chang LS
    Eur Urol; 1994; 26(3):202-6. PubMed ID: 7528661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of nodal metastases at laparoscopic pelvic lymphadenectomy using PSA, Gleason score, and clinical stage in men with localized prostate cancer.
    Hoenig DM; Chi S; Porter C; Tackett L; Smith DS; Cohen SI; Stein BS
    J Endourol; 1997 Aug; 11(4):263-5. PubMed ID: 9376845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of PSA and (pre- postoperative) Gleason in predicting the potential lymphatic involvement in patients with prostatic cancer].
    Gómez Veiga F; Díaz Bermúdez J; Alvarez Castelo L; Lorenzo Patiño MJ; Rodríguez Rivera J; Chantada Abal V; Vázquez Martul E; González Martín M
    Arch Esp Urol; 1997; 50(1):33-9. PubMed ID: 9182486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Micrometastasis (< 1 cm) to Pelvic Lymph Nodes in Prostate Cancer: Role of Preoperative MRI.
    Park SY; Oh YT; Jung DC; Cho NH; Choi YD; Rha KH
    AJR Am J Roentgenol; 2015 Sep; 205(3):W328-34. PubMed ID: 26295669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of digital rectal examination, biopsy Gleason sum and prostate-specific antigen in selecting patients who require pelvic lymph node dissections for prostate cancer.
    Rogers E; Gürpinar T; Dillioglugil O; Kattan MW; Goad JR; Scardino PT; Griffith DP
    Br J Urol; 1996 Sep; 78(3):419-25. PubMed ID: 8881954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The staging pelvic lymphadenectomy: implications as an adjunctive procedure for clinically localized prostate cancer.
    Alagiri M; Colton MD; Seidmon EJ; Greenberg RE; Hanno PM
    Br J Urol; 1997 Aug; 80(2):243-6. PubMed ID: 9284196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting pelvic lymph node involvement in current-era prostate cancer.
    Rahman S; Cosmatos H; Dave G; Williams S; Tome M
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):906-10. PubMed ID: 21300478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of pelvic lymph node metastases by a prostate-specific antigen and prostatic acid phosphatase in clinical T3/T4M0 prostatic cancer.
    Waehre H; Wanderaas EH; Paus E; Fosså SD
    Eur Urol; 1992; 22(1):33-8. PubMed ID: 1385143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer.
    Wyler SF; Sulser T; Seifert HH; Ruszat R; Forster TH; Gasser TC; Bachmann A
    Urology; 2006 Oct; 68(4):883-7. PubMed ID: 17070376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
    Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
    J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open pelvic lymph node dissection for prostate cancer: a reassessment.
    Campbell SC; Klein EA; Levin HS; Piedmonte MR
    Urology; 1995 Sep; 46(3):352-5. PubMed ID: 7544933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of prostate-specific antigen measurements in predicting lymph node involvement in prostatic cancer.
    Arai Y; Yoshiki T; Yamabe H; Yoshida O
    Urol Int; 1990; 45(6):356-60. PubMed ID: 1705062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
    Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
    Partin AW; Kattan MW; Subong EN; Walsh PC; Wojno KJ; Oesterling JE; Scardino PT; Pearson JD
    JAMA; 1997 May; 277(18):1445-51. PubMed ID: 9145716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.